Femasys FEMY
NASDAQ FEMY
$2.96 +0.23 (+8.42%)
At close: Aug 21, 2026 · 4:00 PM EDT

Femasys (FEMY) Amortization of Deferred Charges (2020 - 2026)

Femasys' (FEMY) quarterly Amortization of Deferred Charges came in at $118180.0 in Q1 2026, down 10.61% YoY from $132207.0 in Q1 2025, and down 88.19% on a QoQ basis from $1.0 million in Q4 2025.

Femasys (FEMY) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Femasys (FEMY) has 7 years of Amortization of Deferred Charges data on file, last reported at $118180.0 in Q1 2026.

  • Quarterly Amortization of Deferred Charges fell 10.61% year-over-year to $118180.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 81.57% YoY) and the FY2025 annual result came in at $1.4 million, up 16.31% from the prior year.
  • Amortization of Deferred Charges declined to $118180.0 in Q1 2026, from $1.0 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.0 million in Q4 2025 to a low of $77935.0 in Q4 2022.
  • A 5-year average of $286619.9 and a median of $272181.5 in 2024 frame the typical range for Amortization of Deferred Charges.
  • Annual changes were most pronounced in 2023 — Amortization of Deferred Charges jumped 444.69% — and 2025, when it sank 48.92%.
  • Tracing FEMY's Amortization of Deferred Charges over 5 years: stood at $77935.0 in 2022, then jumped by 444.69% to $424504.0 in 2023, then fell by 20.45% to $337672.0 in 2024, then jumped by 196.4% to $1.0 million in 2025, then slumped by 88.19% to $118180.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $118180.0 (Q1 2026), $1.0 million (Q4 2025), and $426541.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Femasys 9.97 Mn 8.53 Mn 189,391.00

Historic Data

Download Data
DateValue
Mar 31, 2026 118,180.00
Mar 31, 2026 118,180.00
Dec 31, 2025 1.00 Mn
Dec 31, 2025 1.00 Mn
Sep 30, 2025 426,541.00
Sep 30, 2025 426,541.00
Jun 30, 2025 389,913.00
Jun 30, 2025 389,913.00
Mar 31, 2025 132,207.00
Mar 31, 2025 132,207.00
Dec 31, 2024 337,672.00
Dec 31, 2024 337,672.00
Sep 30, 2024 310,540.00
Sep 30, 2024 310,540.00
Jun 30, 2024 285,561.00
Jun 30, 2024 285,561.00
Mar 31, 2024 258,802.00
Mar 31, 2024 258,802.00
Dec 31, 2023 424,504.00
Dec 31, 2023 424,504.00